Boyu Hu

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    ADC Therapeutics
    Topic:
    Consulting
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Celgene/BMS
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    CRISPR Therapeutics
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    08/15/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Morphosys Ag
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Repare Therapeutics
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Caribou Biosciences
    Topic:
    Clinical Trial
    Date added:
    07/27/2022
    Date updated:
    07/03/2024
    Relationship end date:
    07/15/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Artiva Biotherapeutics
    Topic:
    Clinical Trial
    Date added:
    08/09/2023
    Date updated:
    07/03/2024
    Relationship end date:
    08/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    ImmPACT Bio
    Topic:
    Advisory Board
    Date added:
    08/09/2023
    Date updated:
    07/03/2024
    Relationship end date:
    07/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seattle Genetics
    Topic:
    Advisory Board
    Date added:
    08/09/2023
    Date updated:
    07/03/2024
    Relationship end date:
    07/29/2023

Pages

Return to Park City Myeloma and Lymphoma Summit